Please Wait

Applying Filters...

Afrezza
VMF
Table View

Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Afrezza

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 12 USDMF, 3 NDC API, 1 VMF, 3 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

158 Drugs in Development

158 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

41 FDF Dossiers, 5 FDA Orange Book, 9 Europe, 20 Canada, 3 South Africa, 4 Listed Dossiers

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Nanjing Well Pharmaceutical, 1 Capital Farma, 1 Kirsch Pharma, 5 Actylis, 1 BASF, 3 Gangwal Chemicals, 1 Nanjing Bold Chemical, 1 Pluviaendo, 6 Seppic

EXCIPIENTS BY APPLICATIONS

12 Parenteral, 10 Solubilizers, 5 Topical, 3 Surfactant & Foaming Agents, 3 Emulsifying Agents, 3 Film Formers & Plasticizers, 2 Thickeners and Stabilizers, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Co-Processed Excipients, 1 Fillers, Diluents & Binders, 1 Direct Compression